Compound formulations with built-in GI support Many compounded GLP-1 formulations now include ingredients specifically chosen to offset GI side effects
Harvard Health notes these drugs act in the brain to reduce hunger, making it easier to eat less without feeling deprived
Tirzepatide targets both the GLP-1 and glucagon receptors, so its a dual agonist
The interaction data discussed above are extrapolated from the pharmacology of its drug class (GH secretagogues), receptor binding studies, and clinical data from structurally related compounds like growth hormone-releasing peptide-6 (GHRP-6) and growth hormone-releasing peptide-2 (GHRP-2)
We are excited to partner with Biocon for Semaglutide and take this important therapy to the markets where Ajanta has strong on-ground presence and deep reach
These therapies sit within our broader wellness center peptide therapy program, where each protocol is matched to your specific health picture rather than a generic template